These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2683757

  • 1. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
    Waldmann TA, Goldman CK.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757
    [Abstract] [Full Text] [Related]

  • 2. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA, Tsudo M.
    Prog Clin Biol Res; 1988 Nov; 262():283-93. PubMed ID: 2897696
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
    Bich-Thuy LT, Dukovich M, Peffer NJ, Fauci AS, Kehrl JH, Greene WC.
    J Immunol; 1987 Sep 01; 139(5):1550-6. PubMed ID: 3040856
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA, Leonard WJ, Depper JM, Krönke M, Goldman CK, Oh T, Greene WC.
    Princess Takamatsu Symp; 1984 Sep 01; 15():259-68. PubMed ID: 6100644
    [Abstract] [Full Text] [Related]

  • 8. [Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states].
    Mazur G, Frydecka I.
    Acta Haematol Pol; 1993 Sep 01; 24(4):307-13. PubMed ID: 8303976
    [Abstract] [Full Text] [Related]

  • 9. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 10. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
    Dukovich M, Wano Y, Le thi Bich Thuy, Katz P, Cullen BR, Kehrl JH, Greene WC.
    Nature; 2000 Dec 15; 327(6122):518-22. PubMed ID: 3108674
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
    Waldmann TA, Longo DL, Leonard WJ, Depper JM, Thompson CB, Krönke M, Goldman CK, Sharrow S, Bongiovanni K, Greene WC.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
    [Abstract] [Full Text] [Related]

  • 12. Lymphokine receptor-directed therapy: a model of immune intervention.
    Waldmann TA, Grant A, Tendler C, Greenberg S, Goldman C, Bamford R, Junghans RP, Nelson D.
    J Clin Immunol; 1990 Nov 15; 10(6 Suppl):19S-28S; discussion 28S-29S. PubMed ID: 2081786
    [Abstract] [Full Text] [Related]

  • 13. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW, Lord RH, Colby AJ, Diamantstein T, Rickles FR, Dijkstra C, Hogg N, Tilney NL.
    J Immunol; 1987 Jan 01; 138(1):164-70. PubMed ID: 3097143
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A, Bertoglio J, Quillet A, Marchiol C, Wakasugi H, Mishall Z, Fradelizi D.
    J Immunol; 1986 Apr 01; 136(7):2463-9. PubMed ID: 3005412
    [Abstract] [Full Text] [Related]

  • 15. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA.
    Environ Health Perspect; 1987 Nov 01; 75():11-5. PubMed ID: 2891501
    [Abstract] [Full Text] [Related]

  • 16. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
    Ben Aribia MH, Moiré N, Métivier D, Vaquero C, Lantz O, Olive D, Charpentier B, Senik A.
    J Immunol; 1989 Jan 15; 142(2):490-9. PubMed ID: 2783438
    [Abstract] [Full Text] [Related]

  • 17. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.
    Junghans RP, Waldmann TA, Landolfi NF, Avdalovic NM, Schneider WP, Queen C.
    Cancer Res; 1990 Mar 01; 50(5):1495-502. PubMed ID: 2406013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characteristics of the IL-2 receptor expressed on large granular lymphocytes from patients with abnormally expanded large granular lymphocytes. Implication of a non-Tac IL-2-binding peptide.
    Hori T, Uchiyama T, Onishi R, Kamio M, Umadome H, Tamori S, Motoi T, Kodaka T, Uchino H.
    J Immunol; 1988 Jun 15; 140(12):4199-203. PubMed ID: 2836509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.